have suggested a role for L-type Ca 2ϩ channels in regulating intracellular Ca 2ϩ mobilization and PTH release. Other groups, however, found no effects of dihydropyridines on the same parameters (23). Expression of classic L-type channels in parathyroid cells is further contested by the observation that membrane depolarization, which activates L-type Ca 2ϩ channels, has no significant effect on [Ca 2ϩ ] i or parathyroid function (28, 37). These aspects of parathyroid cell signal transduction remain controversial. The current studies were undertaken to address whether parathyroid cells express L-type Ca 2ϩ channels and whether these channels participate in high [Ca 2ϩ ] o -regulated cellular functions.
] ( [Ca 2ϩ ]i) and secretion in these cells. Dihydropyridine channel antagonists dose dependently suppressed Ca 2ϩ -conducting currents, and agonists partially reversed the inhibitory effects of the antagonists in these cells. From a bovine parathyroid cDNA library, we isolated cDNA fragments encoding parts of an ␣ 1S-and a ␤3-subunit of L-type Ca 2ϩ channels. The ␣ 1S-subunit cDNA from the parathyroid represents an alternatively spliced variant lacking exon 29 of the corresponding gene. Northern blot analysis and immunocytochemistry confirmed the presence of transcripts and proteins for ␣ 1-and ␤3-subunits in the parathyroid gland. The addition of dihydropyridines had no significant effects on high [ ] o ) regulate parathyroid hormone (PTH) secretion through the coupling of Ca 2ϩ -sensing receptors (CaRs) to signaling pathways (5) . With Ca 2ϩ binding and CaR activation, phospholipase C activity increases, cAMP production decreases, and intracellular Ca 2ϩ concentrations ([Ca 2ϩ ] i ) rise (4-6, 9, 11, 29) . Studies with pharmacological agents that raise [Ca 2ϩ ] i suggest that incremental changes in this mediator are linked to the inhibition of PTH secretion (27, 30) . High [Ca 2ϩ ] o -induced increases in 1,4,5-inositol trisphosphate are temporally linked to the initial rapid phase of Ca 2ϩ mobilization from intracellular stores (29) , whereas Ca 2ϩ influx across the membrane is probably responsible for sustained changes in [Ca 2ϩ ] i (3) . Studies by Fitzpatrick and colleagues (16, 18, 26) have suggested a role for L-type Ca 2ϩ channels in regulating intracellular Ca 2ϩ mobilization and PTH release. Other groups, however, found no effects of dihydropyridines on the same parameters (23) . Expression of classic L-type channels in parathyroid cells is further contested by the observation that membrane depolarization, which activates L-type Ca 2ϩ channels, has no significant effect on [Ca 2ϩ ] i or parathyroid function (28, 37) . These aspects of parathyroid cell signal transduction remain controversial. The current studies were undertaken to address whether parathyroid cells express L-type Ca 2ϩ channels and whether these channels participate in high [Ca 2ϩ ] o -regulated cellular functions.
On the basis of electrophysiological and pharmacological criteria, voltage-dependent Ca 2ϩ channels (VDCCs) are classified into L-, N-, T-, P/Q-, and R-types (1) . Each of these channels consists of a pore-forming ␣ 1 -subunit and accessory proteins, including ␣ 2 /␦-, ␤-, and ␥-subunits (7, 8, 32, 36) . The structure of the ␣ 1 -subunit determines ion selectivity, voltage sensitivity, and binding specificity to its ligands (7, 33, 36, 38) . L-type VDCCs are characterized by their sensitivity to changes in membrane potential and high affinities for 1,4-dihydropyridines, phenylalkylamines, and benzothiazepines (1, 33, 36) . Three major subtypes of L-type ␣ 1 -subunits have been described, including: 1) the ␣ 1C in heart, smooth muscle, and neurons; 2) the ␣ 1S in skeletal muscle; and 3) the ␣ 1D in neuroendocrine cells (1, 33, 35) . Each ␣ 1 -subunit contains four membraneassociated motifs (I-IV), and each motif is comprised of six membrane-spanning domains (S1-S6). Recent stud-ies have identified the dihydropyridine binding sites in the S5 and S6 domains of motif III (III-S5 and III-S6) and the S6 domain of motif IV (IV-S6) of L-type ␣ 1 -subunits (8, 33) . The sensors of membrane potential are also localized to the S6 domain in each motif (I-IV) (2, 36) . The genomic structure of L-type ␣ 1 -subunits is relatively complex. The human skeletal ␣ 1S -subunit gene, for example, spans 90 kb and consists of 44 exons (20) . Alternatively spliced transcripts of this gene have been identified and possibly contribute to the molecular and functional diversity of L-type ␣ 1 -subunits in different tissues (15, 25) .
We previously identified and characterized nifedipine-sensitive cation-selective currents in parathyroid cells, whose activity increased with rising [Ca 2ϩ ] o (9) . Although these currents can conduct Ca 2ϩ , they are not voltage gated like other dihydropyridine-sensitive L-type channels (9) . These findings suggested that the channels that bind nifedipine and conduct Ca 2ϩ currents in parathyroid cells may differ from classic Ltype channels. To define further the pharmacology and molecular identity of high [Ca 2ϩ ] o -induced, nifedipinesensitive cation currents in these cells, we examined the effects of different dihydropyridine agonists and antagonists on these currents and isolated cDNA fragments encoding L-type channel subunits. We found that the high [Ca 2ϩ ] o -activated Ca 2ϩ currents were modulated in a dose-dependent manner by (ϩ)-and (Ϫ)202-791 and R-and S-BAY K 8644. Clones isolated from a bovine parathyroid cDNA library showed substantial homology to human ␣ 1S -and ␤ 3 -subunits of L-type Ca 2ϩ channels. 
MATERIALS AND METHODS

Materials
R-and S-BAY K 8644 were purchased from Calbiochem (La Jolla, CA). (ϩ)-and (Ϫ)202-791 were obtained from Calbiochem and Novartis Pharma (Basel, Switzerland). Media were prepared by the Cell Culture Facility of the University of California, San Francisco. Antibodies against the ␣ 1-subunit of L-type Ca 2ϩ channels (anti-pan-␣1) were raised against a peptide (pan-␣ 1, amino acid sequence: DNFDYL-TRDWSILGPHHLD) within an intracellular domain between motif IV and the COOH terminus and were affinitypurified by Alomone Labs (Jerusalem, Israel). This epitope is highly conserved among L-type ␣ 1-subunits, including ␣1C, ␣1D, and ␣1S. Donkey anti-rabbit IgG antibodies were purchased from Amersham Life Science (Arlington Heights, IL). Fura 2-AM was obtained from Molecular Probes (Eugene, OR). All other channel blockers, salts, and chemicals were purchased from Sigma Chemical (St. Louis, MO) unless otherwise noted. All sequencing was done by the Biomolecular Resources Center (University of California, San Francisco).
Human parathyroid glands were obtained at the time of surgery for primary hyperparathyroidism according to protocols approved by the Committee on Human Research at the University of California, San Francisco.
Preparation of Parathyroid Cells
Bovine parathyroid cells were isolated after collagenase and DNase digestion of parathyroid gland fragments, as previously described (9) . For electrophysiological studies, isolated cells were plated on no. 1 round coverglasses and incubated for 30 min at 37°C before recording (9) . For measurements of [Ca 2ϩ ]i, cells were cultured on no. 1 round coverglasses for 12-18 h in MEM with FCS (2%) and penicillin/streptomycin (100 U/ml).
Whole Cell Recording
Whole cell voltage clamping was performed using glass pipettes with an electrical resistance of 1-4 M⍀, as previously described (9) . Membrane potential (V m) was controlled, and membrane current (I m) was detected by an Axo-Patch amplifier (Axon Instruments, Foster City, CA). Channel activity was assessed by calculating the membrane conductance (G m) derived from the slope of the Im-Vm plots. Im-Vm plots were created using the following voltage-clamping protocol ( Fig. 1, i ). Cells were held at Ϫ60 mV; then a series of 150-ms test voltage pulses were applied at 2-s intervals in increments of 20 mV from Ϫ100 to ϩ120 mV. The current traces were recorded from 20 ms before to 25 ms after each applied voltage pulse. The downward and upward deflections represent the inward and outward currents, respectively. Arrows in Figs. 1-3 represent zero current level. Membrane currents used for making I m-Vm plots are the arithmetic means of the currents recorded during the voltage pulses. Representative experiments are shown in Figs. 1-3 , and all experiments were performed on Ն3 cells at room temperature, unless otherwise specified.
Electrode solutions. Recordings were performed with a whole cell electrode solution (WCES) containing (in mM): 140 Cs-MES, 5 MgCl 2, 10 EGTA, 10 HEPES (pH 7.4), 4 MgATP, 0.3 GTP, and a nucleotide-regenerating system (NRS: 14 mM phosphocreatine and 50 U/ml creatine phosphokinase) (9) .
Bath solutions and extracellular bath perfusion. All bath solutions (BS) contained 10 mM HEPES (pH 7.4) and 10 mM tetraethylammonium (TEA ϩ ) to block endogenous K ϩ currents (9) . Various [Ca 2ϩ ] in the BS (0.7-90 mM) were achieved by the addition of Ca acetate. Acetate was used as the anion charge-carrier to minimize the activity of endogenous Cl Ϫ currents (9) . Osmolarity of the BS was adjusted to Ϸ330 mosM/l with sucrose as needed. Each BS is specified by the concentration of its major cation species as follows Recording and cell perfusion were done in a Lucite perfusion chamber with a volume of 0.8 ml, as previously described (9) . Channel antagonists and agonists were premixed with appropriate BS and then delivered to the recording chamber. All recordings were initiated Ն10 min after delivery of a given BS.
Screening of PTH cDNA Library
A bovine parathyroid ZAP II cDNA library, prepared from newborn calf parathyroid poly A ϩ RNA (Stratagene, La Jolla, CA), was screened according to the manufacturer's instructions. Briefly, cDNA was first mixed with and allowed to infect XL1-Blue Escherichia coli. Infected cells were then plated on 150-mm agar plates (50,000 pfu/plate) and grown at 37°C for 8-12 h until plaques were clearly identified. Nitrocellulose membrane replicas of the plates were fixed and probed for the gene of interest by use of standard DNA-DNA hybridization with probes prepared from a rat aorta ␣1-subunit [VASM ␣-1.3 (22) ] and a human ␤3-subunit cDNA (12) . Positive plaques were isolated, and pBluescript SK(Ϫ) phagemids containing inserts of interest were excised from ZAP II according to the manufacturer's instructions. Excised pBluescript SK(Ϫ) phagemids were amplified, and inserts were sequenced. Approximately 10 6 pfus were screened with the ␣-1.3 and ␤3 cDNA probes.
RT-PCR
Total and poly A ϩ RNA were isolated from newborn calf parathyroid glands and human parathyroid adenomas with an RNA Stat-60 kit (10) . The primers used for bovine (upper: 5Ј-ACAACCAGTCAGAGCAAATG-3Ј; lower: 5Ј-ACACGGAA-CAGGCGG AAGAA-3Ј) and human (upper: 5Ј-TGGCCT-TCACTATCATCTTC-3Ј; lower: 5Ј-GGGTTCGCACTCCT-TCTG-3Ј) ␣ 1S-subunits were derived from the sequences of the bovine parathyroid cDNAs identified in this study (PT ␣1-1) and the human skeletal muscle homologue (20) (GenBank: L33798). PCR was performed on the first strand cDNA reverse transcribed from bovine or human parathyroid poly A ϩ RNA (Ϸ0.5 g), as described. The following reaction temperatures and durations were used: 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min, each for 30 cycles. The reaction ended with a 7-min extension at 72°C. PCR products were electrophoresed on agarose gels, visualized by ethidium bromide staining, subcloned into pT-Adv (Clontech Laboratories, Palo Alto, CA) or PCR II-TOPO (Invitrogen, Carlsbad, CA) vectors by use of TA cloning methods according to the manufacturer's instructions, and sequenced.
Immunocytochemistry
Immunocytochemistry of bovine parathyroid sections was performed as described (10) using the anti-pan ␣ 1 antiserum (4 ϫ 10 Ϫ7 M). To assess specificity, sections were treated with either antiserum preincubated with excess peptide (2.4 ϫ 10 Ϫ5 M) or nonimmune rabbit IgG. After diaminobenzene (DAB) staining, cells or sections were counterstained with aqueous hematoxylin (10) . Experiments were repeated four times on tissue sections from two animals.
Measurement of [Ca 2ϩ
]i and PTH Release [Ca 2ϩ ]i was determined using an InCyt Im2 imaging system (Intracellular Imaging, Cincinnati, OH) with a ϫ40 Nikon Fluor objective. Briefly, cells were loaded with fura 2-AM (3 M) in buffer A [20 mM HEPES (pH 7.4), 120 mM NaCl 5 mM KCl, 1 mM MgCl 2, 1 mg/ml pyruvate, 1 mg/ml glucose, and 1.0 mM CaCl2] at 37°C for 30-40 min. After three washes with buffer A, cells were incubated at 37°C for 15-30 min before recording. Fluorescent emission (510 nm) was detected by a COHU high-performance charge-coupled device camera (COHU, San Diego, CA), digitized, and stored in a microcomputer. The 340/380 excitation ratio (R 340/380) of emitted fluorescence was calculated.
PTH release was measured from cells treated with vehicle (0.1% ethanol) or dihydropyridines (10 Ϫ6 M) for 30 min at 37°C (31) .
Statistics
Data, normalized to baseline activity in individual experiments, were combined and reported as means Ϯ SE. Statistical significance was determined by ANOVA with an f-test using Microsoft Excel computer software (Microsoft, Seattle, WA).
RESULTS
Dihydropyridine Agonists and Antagonists Modulate Ca 2ϩ -Conducting Currents
In previous studies, we characterized two types of Ca 2ϩ -conducting currents in bovine parathyroid cells. Type 2 currents, which were insensitive to Cd 2ϩ and nifedipine, could be blocked by La 3ϩ and Gd 3ϩ (9, 10) . To determine whether type 1 currents were sensitive to other dihydropyridines, we tested the effects of (ϩ)-and (Ϫ)202-791 and R-and S-BAY K 8644 on high [Ca 2ϩ ] o -induced Ca 2ϩ currents. As shown in Fig. 1 , the dihydropyridine antagonist (Ϫ1)202-791 suppressed I m and G m in a dose-dependent manner (10 Ϫ10 to 3 ϫ 10 Ϫ7 M), with an IC 50 of Ϸ10 Ϫ9 M. In the presence of a maximum dose of (Ϫ)202-791, the residual type 2 currents that accounted for Ϸ50% of total currents were further blocked by La 3ϩ (3 ϫ 10 Ϫ3 M). The reversal potential (V r ), derived from I m -V m plots, did not shift significantly with (Ϫ)202-791 (data not shown), suggesting that this blocker did not affect the ion selectivity of these currents. These results are compatible with our previous findings for nifedipine and indicate that dihydropyridines affect only type 1 currents.
The effects of (Ϫ)202-791 on the Ca 2ϩ -conducting currents could be partially reversed by its isomeric counterpart (ϩ)202-791, as demonstrated in Fig. 2 . In a representative experiment, addition of (Ϫ)202-791 (10 Ϫ8 M) suppressed I m and G m by Ϸ60% (Fig. 2A, i and ii, and B). Subsequent perfusion of the cell with (ϩ)202-791 (3 ϫ 10 Ϫ6 M) partially restored I m ( Fig. 2A,  iii) and G m (Fig. 2B) . Recovery of I m and G m was not due to damage to the membrane-pipette seal, because both parameters could be suppressed by Cd 2ϩ , a blocker of type 1 currents (Fig. 2A, iv, and B) , and La 3ϩ (Fig. 2B) .
R-and S-BAY K 8644 also modulated type 1 currents in parathyroid cells. As shown in Fig. 3 , the I m and G m induced by high [Ca 2ϩ ] o (i and ii) were suppressed by R-BAY K 8644 (10 Ϫ6 M) (iii). The inhibitory effects of R-BAY K 8644 were reversed by addition of S-BAY K 8644 (10 Ϫ5 M), an L-type channel agonist (Fig. 3iv) . Again, the recovery of I m and G m by S-BAY K 8644 was not the result of leakage of the membrane seal, because these parameters could be further suppressed by nifedipine (10 Ϫ5 M; Fig. 3v ) and Gd 3ϩ (3 ϫ 10 Ϫ3 M; Fig. 3 vi) . These studies strongly suggest that dihydropyridinesensitive L-type channels are present in parathyroid cells. The insensitivity of Ca 2ϩ -conducting currents to membrane potential, however, suggested that the channel subunits interacting with dihydropyridines and responsible for conducting Ca 2ϩ currents in these cells may differ from classic L-type VDCCs.
Cloning of Parathyroid Channel Subunit cDNAs
To determine the identity of putative L-type channel subunits in parathyroid cells, we screened a parathyroid cDNA library for the presence of L-type ␣ 1 -and ␤ 3 -subunit cDNAs. We isolated three partial ␣ 1 -subunit cDNAs with sizes of Ϸ3.3 kb (PT␣ 1 -1), Ϸ0.8 kb (PT␣ 1 -2), and Ϸ0.3 kb (PT␣ 1 -3) . Sequencing revealed that clones PT␣ 1 -2 and PT␣ 1 -3 were part of the PT␣ 1 -1 clone (data not shown). The nucleotide and predicted amino acid sequences of PT␣ 1 -1 were 86 and 88% identical to those of the human skeletal muscle ␣ 1S -subunit, respectively (Fig. 4A and data not shown) . Using the same library, we also isolated a partial ␤ 3 -subunit cDNA (Ϸ488 bp) whose predicted amino acid sequence was 99% identical to the human VDCC ␤ 3 -subunit (Fig. 4B) . The amino acid sequences derived from the PT ␣ 1 -1 cDNA clone revealed the presence of putative dihydropyridine-binding domains (Fig. 4A, III-S5 , III-S6, and IV-S6 domains) and membrane potential sensors (III-S6 and IV-S6 domains). One striking difference between the PT␣ 1 -1 clone and the human skeletal ␣ 1S homologue is a deletion of 19 amino acids within the linkers between the IV-S3 and IV-S4 domains. These amino acids are encoded by 57 nucleotides, consisting of exon 29 of the ␣ 1S -subunit gene (20) . To confirm whether such a deletion resulted from alternative transcript splicing or was a cloning artifact, we performed RT-PCR using poly A ϩ RNA isolated from bovine parathyroid and human parathyroid adenoma tissue. In four experiments from three separate RNA preparations, we consistently amplified ␣ 1 -subunit cDNA lacking exon 29 from bovine ( Fig. 5A ) and human ( Fig. 5B ) parathyroid tissues. These findings indicated that the parathyroid gland predominantly expresses the alternatively spliced variant of the L-type ␣ 1 -subunit.
RNA and Protein Expression of the L-type ␣ 1 -and ␤ 3 -Subunit in PTH
To examine the sizes of the full-length transcripts for the parathyroid ␣ 1 -and ␤ 3 -subunits, we performed Northern blot analysis. With probes made from the PT␣ 1 -1 and the human ␤ 3 -subunit cDNA, we identified, respectively, a 6-kb and 3.8-kb transcript in the parathyroid (Fig. 6) . The sizes of these transcripts were comparable to those of the rabbit skeletal muscle ␣ 1 -subunit and human ␤ 3 -subunit transcripts, respectively (12, 14, 34) .
To assess the protein expression of ␣ 1 -subunits in parathyroid cells, we performed immunocytochemistry using an anti-pan-␣ 1 antiserum raised against an epitope that is conserved among ␣ 1C -, ␣ 1S -, and ␣ 1D -subunits. Brown DAB staining for the ␣ 1 -subunit was localized to parathyroid cells and smooth muscle cells of nearby arterioles and venules (Fig. 7, a and b) . Preincubation of antibodies with pan-␣ 1 peptide prevented staining, indicating specificity of the antibody (Fig. 7c) . These findings further confirmed the presence of L-type Ca 2ϩ channels in parathyroid cells.
Effects of Dihydropyridines on the Intracellular Ca 2ϩ Concentration and PTH Secretion in Parathyroid Cells
To test whether the dihydropyridine-sensitive type 1 current contributes to the high [Ca 2ϩ ] o -induced increases in [Ca 2ϩ ] i in parathyroid cells, we measured [Ca 2ϩ ] i by microfluorimetry in the presence and absence of (Ϫ)202-791 and R-BAY K 8644. As shown, adding (Ϫ)202-791 (10 Ϫ6 M) had no significant effect on the sustained (Ͼ5 min) increase in [Ca 2ϩ ] i induced by raising [Ca 2ϩ ] o from 0.5 to 2.0 mM (Fig. 8A) (27, 30) . In parathyroid cells, initial increases in [Ca 2ϩ ] i that re- sult from raising [Ca 2ϩ ] o are thought to be mediated by Ca 2ϩ released from intracellular stores (24, 29 (17) showed that the L-type channel agonist (ϩ)202-791 suppressed and the antagonist (Ϫ)202-791 enhanced PTH secretion in dispersed adult bovine parathyroid cells. This group (Fitzpatrick et al., 18) also detected by use of an L-type channel antiserum a protein in parathyroid cell lysates with a size (Ϸ150 kDa) comparable to the skeletal ␣ 1s -subunit. Furthermore, incubation of cells with this same antiserum reduced PTH secretion, suggesting that this antiserum could bind to and activate the putative Ca 2ϩ channel. In support of this possibility, increased isotopic Ca 2ϩ flux was also demonstrated after preincubation of cells with this antibody (18) . Other evidence linking L-type channels to parathyroid function was reported by Cooper et al. (13) , who showed that BAY K 8644 increased [Ca 2ϩ ] i and Ca 2ϩ influx in parathyroid cells. In the current investigation, we recorded membrane currents that were sensitive to dihydropyridines in isolated parathyroid cells. Our immunocytochemistry and Northern blotting provided evidence that protein and mRNA encoding putative L-type ␣ 1 -and ␤-subunits were expressed in these cells. Finally, cloning and RT-PCR data confirmed the presence of an alternatively spliced skeletal ␣ 1S -subunit in these cells. Taken together, our observations and those of other investigators support the idea that parathyroid cells express a skeletal muscle-like isoform of the L-type Ca 2ϩ channel and that these channels might mediate changes in [Ca 2ϩ ] i and PTH release.
Our functional studies, however, yielded somewhat unexpected results, given the work of others summarized above and our own electrophysiology experiments. We were unable to demonstrate statistically significant effects of dihydropyridines on high [Ca 2ϩ ] oinduced increases in [Ca 2ϩ ] i in parathyroid cells or PTH release with a variety of acute and short-term incubation protocols. These observations confirm those of Muff et al. (23) , who found no effects of (Ϯ)202-791 on PTH release or [Ca 2ϩ ] i . At present, we have no explanation for the inconsistencies in studies with dihydropyridines among different laboratories. They may be attributed to differences in methods and reagents. Variations could also be due to the ages of the animals from which parathyroid tissues were obtained. Our studies and those of Muff et al. (23) employed glands from newborn calves, whereas Fitzpatrick and coworkers (16) (17) (18) used adult bovine parathyroid glands. The expression of L-type ␣ 1 -subunits may be developmentally regulated in certain tissues. For instance, ␣ 1 -subunit expression increases in the adult brain compared with embryonic brain (15) . Whether the expression of L-type Ca 2ϩ channel subunits increases with age in the parathyroid and whether these subunits become functional in mediating Ca 2ϩ influx only in cells from adult glands are possibilities that will require further investigation.
The partial ␣ 1 -subunit cDNA we cloned from the parathyroid appears to be an alternatively spliced product of the skeletal muscle ␣ 1s -subunit gene (20) . This cDNA lacks the 57 nucleotides that correspond to exon 29 of the human homolog of this gene and that encode 19 amino acids within the linker between IV-S3 and IV-S4 domains. Such a deletion would shorten this extracellular loop from 32 to 13 amino acids. Similar spliced products have been previously identified in skeletal muscle-like BC3H1 cells, mouse ovary, rabbit intestinal smooth muscle, and rat brain (15, 25) . Our RT-PCR experiments detected only cDNAs lacking exon 29 in bovine and human parathyroid tissues, suggesting that the spliced variant is the predominant one expressed in the parathyroid. The significance of such a structural modification on channel function in any system, however, remains unclear.
Parathyroid cells are nonexcitable. Membrane depolarization by high K ϩ does not induce Ca 2ϩ influx (28, 37) . The lack of a response to depolarizing concentrations of K ϩ could be due to the lack of expression of classic VDCCs (i.e., dihydropyridine-responsive channels) or the expression of channels with altered voltage-sensing properties. Our electrophysiological data support the latter possibility (9) . Using a traditional whole cell patch-clamp configuration, we recorded dihydropyridine-sensitive membrane currents in parathyroid cells that were voltage independent. Their affinity for dihydropyridines, however, was comparable to that of classic VDCCs. The nifedipine-sensitive currents in parathyroid cells were cation nonselective, in contrast to typical VDCCs in excitable cells, which exhibit significant selectivity for Ca 2ϩ . We did not record other voltage-sensitive Ca 2ϩ -conducting currents with the same protocols. It is therefore likely that the channels that bind dihydropyridines in parathyroid cells are not sensitive to changes in membrane potential.
Clearly, because their electrophysiological properties differ, the molecular characteristics of the responsible channel subunits in parathyroid cells must diverge from classic L-type VDCCs. By surveying the deduced partial amino acid sequence of the parathyroid ␣ 1 -subunit cDNA, we were able to identify the putative dihydropyridine-binding domains (i.e., III-S5, III-S6, and IV-S6) and membrane potential-sensing domains (i.e., III-S4 and IV-S4). The expression of dihydropyridine-binding regions supports data showing that these drugs bind to parathyroid cell membranes (21) . The presence of voltage-sensing domains may, however, contradict our electrophysiological results, because the dihydropyridine-blockable currents we recorded were not classically voltage gated. Because the 3.3-kb parathyroid ␣ 1 -subunit cDNA we cloned represents only Ϸ50% of the full-length transcript, it is likely that modifications in the as-yet-unknown portions of the cDNA could potentially alter the ability of the channels to sense changes in membrane potential. The confirmation of this possibility requires the cloning of the full-length parathyroid ␣ 1 -subunit cDNA. Alternatively, the protein product of the full ␣ 1 -subunit, whose partial clone we identified, may not mediate the voltage-insensitive currents in these cells. Other asyet-unidentified channel subunits may be responsible for conducting these currents, or other channel regulators or subunits may modify the voltage dependency of the multisubunit channel complex in parathyroid cells.
A major unresolved issue inherent in these data is the difference between the electrophysiological and microfluorimetric findings. Electrophysiological recordings clearly show that dihydropyridine agonists and antagonists activate or block, respectively, cation currents in parathyroid cells that are responsive to changes in [Ca 2ϩ ] o and that can be carried by Ca 2ϩ (9 ] i may not change with these drugs. In support of this possibility, our previous studies clearly show that these currents can be conducted by divalent as well as monovalent cations. Given the lack of available parathyroid-derived cDNAs for the other channel subunits, it is not possible to address definitively the basis for different results from electrophysiological vs. microfluorimetric studies.
The differences between the two types of data emphasize the importance of using electrophysiological approaches as a guide for hypothesis generation and protocol development. Ultimately, physiological principles must always be tested in intact cells, and eventually in animals, to assure that they are valid with respect to physiological events in vivo, including hormone secretion and second-messenger generation. A more complete understanding of the functions served by dihydropyridine channel subunits in nonexcitable tissues will eventually require more complete information on the subunit structure and molecular properties of the ion channels expressed in the parathyroid.
